ANDA 40277, held by Rising Pharmaceuticals. Proparacaine Hydrochloride.
As of Nov 22, 2026, ANDA 40277 (Proparacaine Hydrochloride), held by Rising Pharmaceuticals, was first approved by FDA on Mar 16, 2000, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 16, 2000 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Proparacaine Hydrochloride0.5% · solution/drops;ophthalmic | Proparacaine Hydrochloride | Rx |
| Aug 23, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Mar 16, 2000 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters